The number of patients diagnosed with a potentially blinding eye infection associated with injecting drugs, such as fentanyl or heroin, has more than doubled

Please be advised that the ZEISS MYO 200 is not included in the Australian Register of Therapeutic Goods (ARTG) and is therefore not available

Ophthalmologists attending The Australasian Society of Cataract and Refractive Surgeons (AUSCRS) annual conference, this year on the Sunshine Coast in Queensland, will be among

Alcon and RxSight, an ophthalmic medical device company, have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PC IOLs).